Odisha's KIMS Performs First Corneal Transplant, Restores Vision Of 37-Year-Old
The surgery was performed by a team of ophthalmologists led by Dr Akshit Gupta.
Alcon Expands Its Cell Therapy Ambitions With $550M Neurotech Pharma Acquisition
Alcon’s Neurotech Pharmaceuticals acquisition brings the rare vision disorder cell therapy Encelto as well as the platform technology that developed it. Last year, Alcon acquired a...
J&J’s $2.2B Ollin Buyout Brings Late-Stage Eye Drug; Blackstone Deal Adds Trial Funding
Johnson & Johnson’s Ollin Biosciences acquisition comes with a Phase 3-ready bispecific antibody. The companies say this eye drug offers advantages over Vabysmo, a Roche drug a...
Orthokeratologist.org Launches To Unite Orthokeratologists Around The World
Orthokeratologist.org, the world’s first dedicated community for orthokeratologists, has launched today with a global call out to all orthokeratologists to step forward and be coun...
Secure Patient Messaging in Ophthalmology: Retrospective Natural Language Processing Study
Background: The rapid rise of secure patient messaging has transformed ophthalmic communication, with text volumes now exceeding prepandemic levels across health care systems. Our...
ER-100 – aging reversal drug first test results in the EYE with Glaucoma announced
Safety phase. 2 of 3 patients given LOW DOSES reported vision improvement. Phase 2 – Doses will now triple in size for next round. Today, at the American Academy of Ophthalmology A...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.